AbbVie Inc. (NYSE:ABBV)

Top Presentations to Look for at ASCO

It almost the end of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. The 2017 annual meeting ...
Read Full Story »

Big Pharma Has Big Catalysts Coming for the Rest of 2017

The big pharmaceutical stocks are one area that has done somewhat better this year. One major reason for that is the shrill rhetoric from politicians has quieted as the election ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Why This Humira Patent Loss Might Not Be What You Think

AbbVie Inc. (NYSE: ABBV) watched its shares slide on Wednesday following a ruling from the U.S. Patent and Trade Mark Office Trial and Appeals Board that found in favor of ...
Read Full Story »

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse analyst Vamil Divan has released an outlook on the pharmaceutical sector. While the weighting for the sector is Market Weight, there are some positives in the call. The ...
Read Full Story »

Short Interest in Major Pharma Shrinks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Jefferies Makes a Huge Surprise Addition to Franchise Picks Portfolio

With earnings for the first quarter winding down and the second quarter well underway, many of the top companies we follow on Wall Street are making some changes to the ...
Read Full Story »

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Earnings season is now in full swing, and we have put together a preview of some of the world’s largest biotechnology and pharmaceutical companies reporting their earnings on Thursday. With ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

One thing that crept on the radar screen last week is that after eight years of a bull market, five of which are of the secular variety, after the S&P 500 ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Back Off Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, KLA-Tencor, Marathon Oil, Verifone and Many More

Stocks were indicated higher ahead of Friday's key payrolls and unemployment report, but there has been a softer tone in recent days as some selling has taken place. The bull ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Frontier Communications, Hyatt Hotels, Weatherford International and Many More

Stocks were indicated to open marginally lower on Tuesday. Now that the bull market is officially eight years old, 24/7 Wall St. took a look at the then versus now headlines with ...
Read Full Story »